Prescient Therapeutics (PTX) has announced three internal development programs for its immune receptor technology platform, OmniCAR. OmniCAR is a next-generation CAR T therapy platform that…

Following more than a decade of treatments, cancer survivor Laurie Adami now plans to tackle the world’s tallest mountain to raise awareness of the drugs…

An American woman who owes her life to a bespoke cancer treatment is speaking out to raise awareness of the procedure, CAR T cell therapy….

Laurie Adami has had a long and intricate journey with blood cancer, after being diagnosed with Non-Hodgkin Lymphoma in 2006. Over the next 12 years,…

Cancer is a word we all dread to hear yet a cure for the deadly disease has always felt so far away. However, thanks to…

In the battle against blood cancer, chimeric antigen receptor T cell (CAR-T) therapy is proving to be a shining light on the horizon. Dr Allen…

Special Report: A form of immunotherapy that involves modifying a patient’s white blood cells so they recognise and target cancer cells is shaping up as…

Today, we will acquaint you with the product pipeline of ASX-listed clinical-stage biotechnology company Prescient Therapeutics Limited (ASX:PTX). Prescient Therapeutics is gaining attention for its remarkable progress…

StockTalk is a Stockhead video series featuring a roundtable of experts discussing a new investment topic each week. In this edition, host Dr Nigel Finch discusses ASX…

When local synthetic antibiotics developer Recce Pharmaceuticals announced they had entered into an antiviral Sars-CoV-2 screening program in partnership with the CSIRO and the University…